Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Completed 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 181Breast Neoplasms 154Prostatic Neoplasms 144Lung Neoplasms 139Glioblastoma 119Head and Neck Neoplasms 115Squamous Cell Carcinoma of Head and Neck 110Rectal Neoplasms 107Lymphoma 101Esophageal Neoplasms 100Pancreatic Neoplasms 76Esophageal Squamous Cell Carcinoma 71Leukemia 70Neoplasms 67Brain Neoplasms 67Lymphoma, Follicular 63Precursor Cell Lymphoblastic Leukemia-Lymphoma 62Lymphoma, Non-Hodgkin 62Lymphoma, Large B-Cell, Diffuse 58Hodgkin Disease 56Uterine Cervical Neoplasms 53Central Nervous System Neoplasms 53Leukemia, Lymphocytic, Chronic, B-Cell 52Gliosarcoma 51Sarcoma 50Colorectal Neoplasms 50Neoplasm Metastasis 45Lymphoma, Large-Cell, Immunoblastic 45Glioma 44Burkitt Lymphoma 43

Interventions

Cisplatin 6Radiotherapy 5Fluorouracil 3Docetaxel 3Platinum 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Carboplatin 21,2-diaminocyclohexaneplatinum II citrate 2toripalimab 1dehydroftorafur 1camrelizumab 1antineoplaston AS 2-1 1antineoplaston A10 1X-Rays 1Transurethral Resection of Bladder 1Therapeutics 1Specimen Handling 1Referral and Consultation 1Radiotherapy, Intensity-Modulated 1Radiation 1Observation 1Magnetic Resonance Spectroscopy 1Eucalyptus Oil 1Etoposide 1Erlotinib Hydrochloride 1Endoscopy 1Endoscopic Mucosal Resection 1Coal Tar 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Paranasal Sinus Neoplasms × Radiotherapy × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

NCT06940180 2025-06-26

Toripalimab With Chemotherapy for Sinus Cancer

Dana-Farber Cancer Institute

Phase 2 Recruiting
20 enrolled
Head & Neck

Sinonasal undifferentiated carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Paranasal Sinus Neoplasms

NCT00117572 2018-04-09

DeCIDE

University of Chicago

Phase 3 Completed
285 enrolled 22 charts
Head & Neck

Laryngeal Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00462735 2018-03-13

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
33 enrolled 15 charts
Head & Neck

Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Paranasal Sinus Neoplasms, Pharyngeal Neoplasms

NCT00347256 2008-12-10

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer

University of Tennessee

Phase NA Withdrawn
60 enrolled

Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡